COVID-19 and closures won’t stop us from sharing the incredible lessons we can learn from studying medical care during the Civil War!
Join us on Friday, May 28 at 1:00 PM on YouTube for a virtual program hosted by the National Museum of Civil War Medicine. You can tune in live by visiting youtube.com/user/nmcwm at the scheduled time.
Education Coordinator John Lustrea will talk with Mark Breazzano, M.D., Assistant Professor of Ophthalmology at Johns Hopkins University, about the parallels between Civil War medicine and modern medicine. As someone currently working in the medical field and an avid student of history, Dr. Breazzano offers a unique perspective on Civil War medicine. From the importance of sufficient medical supplies, to vaccines, to new understandings of disease spread, the Civil War offers many important lessons for doctors today.
Mark Breazzano, M.D., is a retina specialist and experienced surgeon seeing patients at the Wilmer Eye Institute’s locations in Frederick and Baltimore, Maryland. He specializes in the diagnosis and treatment of medical and surgical vitreoretinal diseases including macular degeneration, diabetic retinopathy, retinal detachment, epiretinal membranes, macular holes and more. Dr. Breazzano is an award-winning researcher and surgeon who holds a patent and has authored more than 80 publications including peer-reviewed papers, book chapters and abstracts that span a diverse selection of vitreoretinal diseases. His research has been featured in WebMD, Newsday, Medscape, American Council on Science and Health, and American Academy of Ophthalmology’s EyeNet Magazine. His research is focused on accurate determination of endophthalmitis in the setting of Candida bloodstream infections and optimizing medical and surgical management for blinding diseases.
Like these programs? Consider supporting our efforts by becoming a member or donating to the Museum! Your efforts ensure that we can continue sharing the story of Civil War medicine in this crucial time. In history, we can find hope amid our struggle against COVID-19.